Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Organ Preservation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03377283
What this trial is testing

Peri-operative rATG-perfusion of Solid Transplants

Who this might be right for
Organ Preservation Solutions
Medical University Innsbruck 80
Testing effectiveness (Phase 2)Study completedNCT04380337
What this trial is testing

Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer

Who this might be right for
Rectal Cancer
Stanford University 38
Not applicableStudy completedNCT00534729
What this trial is testing

Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA

Who this might be right for
Laryngeal NeoplasmsHypopharyngeal Neoplasms
King Faisal Specialist Hospital & Research Center 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07543848
What this trial is testing

A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer

Who this might be right for
Rectal NeoplasmsRectal Adenocarcinoma
Chongqing University Cancer Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06039631
What this trial is testing

Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer

Who this might be right for
Larynx CancerHypopharyngeal Cancer
Fudan University 82
Testing effectiveness (Phase 2)Study completedNCT01273051
What this trial is testing

Transanal Endoscopic Microsurgery (TEM) After Radiochemotherapy for Rectal Cancer

Who this might be right for
Rectal Tumour
Radboud University Medical Center 55
Large-scale testing (Phase 3)Looking for participantsNCT06339060
What this trial is testing

An Organ Preservation Strategies After Chemoradiotherapy Combined With Immunotherapy for Esophageal Cancer (PALACE3).

Who this might be right for
Esophageal Cancer
Ruijin Hospital 356
Testing effectiveness (Phase 2)Ended earlyNCT00002735
What this trial is testing

SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue

Who this might be right for
Head and Neck Cancer
SWOG Cancer Research Network 68
Not applicableStudy completedNCT03831048
What this trial is testing

Donors After Circulatory Death Heart Trial

Who this might be right for
Heart Transplant
TransMedics 180
Not applicableStudy completedNCT03031067
What this trial is testing

Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Marginal Graft

Who this might be right for
Liver DiseasesKidney Diseases
Matteo Ravaioli 20
Testing effectiveness (Phase 2)Looking for participantsNCT07292298
What this trial is testing

Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

Who this might be right for
Rectal AdenocarcinomaRectal Cancer
University of Colorado, Denver 44
Testing effectiveness (Phase 2)Temporarily pausedNCT04558684
What this trial is testing

Radiotherapy With Neoadjuvant Chemotherapy and Immunotherapy in Rectal Cancer

Who this might be right for
Rectal CancerRadiotherapyImmunotherapy+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03493425
What this trial is testing

Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery

Who this might be right for
Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7Stage IVA Sinonasal Squamous Cell Carcinoma AJCC v7
ECOG-ACRIN Cancer Research Group 82
Not applicableNot Yet RecruitingNCT07744958
What this trial is testing

RESTORE-BLADDER (REgistry on STrategies for Organ pREservation in Muscle-invasive BLADDER Cancer)

Who this might be right for
Muscle Invasive Bladder Cancer (MIBC)
Heinrich-Heine University, Duesseldorf 100
Not applicableNot Yet RecruitingNCT07348874
What this trial is testing

Predictive Accuracy of Machine Perfusion for Kidney Transplant Outcomes in Germany

Who this might be right for
Kidney TransplantRenal TransplantOrgan Preservation
University Hospital Heidelberg 300
Testing effectiveness (Phase 2)UnknownNCT01073683
What this trial is testing

Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal Cancer

Who this might be right for
Larynx Cancer
Rabin Medical Center 100
Not applicableStudy completedNCT05194306
What this trial is testing

PERTRIAL - Perla® Preservation Solution

Who this might be right for
Organ TransplantIschemic Reperfusion Injury
Advanced Life Solutions 11
Not applicableLooking for participantsNCT07616297
What this trial is testing

Higher Radiation Dose to the Tumor May Help Avoid Surgery in Rectal Cancer Patients

Who this might be right for
Rectal CancerRadiation Oncology
Claudia Schuurhuizen 25
Not applicableStudy completedNCT04615182
What this trial is testing

Donor After Circulatory Death Heart CAP Trial

Who this might be right for
Heart Transplant
TransMedics 90
Not applicableLooking for participantsNCT07423936
What this trial is testing

Multimodal Neuromonitoring During Normothermic Regional Perfusion for Organ Donors Determined Dead by circuLatory Criteria Following Withdrawal of Life Sustaining Measures

Who this might be right for
Organ PreservationBrain Reperfusion or Regain of Brain Function During Normothermic Regional Perfusion
University of British Columbia 30
Next Page